References for supplementary material online
S1
Sanders JE et al. (1983) Late effects on gonadal function of cyclophosphamide,
total-body irradiation, and marrow transplantation. Transplantation 36: 252–255
S2
Watson AR et al. (1985) Long term effects of cyclophosphamide on testicular
function. Br Med J (Clin Res Ed) 291: 1457–1460
S3
Richter P et al. (1970) Effect of chlorambucil on spermatogenesis in the human
with malignant lymphoma. Cancer 25: 1026–1030
S4
Calamera JC et al. (1979) Biochemical changes of the human semen produced
by chlorambucil, testosterone propionate and human chorionic gonadotropin
administration. Andrologia 11: 43–50
S5
Da Cunha MF et al. (1983) Active sperm production after cancer chemotherapy
with doxorubicin. J Urol 130: 927–930
S6
Pont J and Albrecht W (1997) Fertility after chemotherapy for testicular germ
cell cancer. Fertil Steril 68: 1–5
S7
Wallace WH et al. (1989) Gonadal dysfunction due to cis-platinum. Med
Pediatr Oncol 17: 409–413
S8
Ahmed SR et al. (1983) Primary gonadal damage following treatment of brain
tumors in childhood. J Pediatr 103: 562–565
S9
Longhi A et al. (2003) Fertility in male patients treated with neoadjuvant
chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 25: 292–296
S10
Lendon M et al. (1978) Testicular histology after combination chemotherapy in
childhood for acute lymphoblastic leukaemia. Lancet 2: 439–441
S11
Chatterjee R et al. (2000) Testicular and sperm DNA damage after treatment
with fludarabine for chronic lymphocytic leukaemia. Hum Reprod 15: 762–766
S12
Sanders JE et al. (1988) Ovarian function following marrow transplantation for
aplastic anemia or leukemia. J Clin Oncol 6: 813–818
S13
Freckman HA et al. (1964) Chlorambucil-Prednisolone Therapy For
Disseminated Breast Carcinoma. JAMA 189: 23–26
S14
Galton DA et al. (1958) Busulfan (1, 4-dimethanesulfonyloxybutane, myleran);
summary of clinical results. Ann N Y Acad Sci 68: 967–973
S15
Belohorsky B et al. (1960) Comments on the development of amenorrhea
caused by myeleran in cases of chronic myelosis. Neoplasma 7: 397–402
S16
Fisher B et al. (1979) 1-phenylalanine mustard (L-PAM) in the management of
premenopausal patients with primary breast cancer: lack of association of disease-free
survival with depression of ovarian function. National Surgical Adjuvant Project for
Breast and Bowel Cancers. Cancer 44: 847–857
S17
El-Beheiry A et al. (1979) Methotrexate and fertility in men. Arch Androl 3:
177–179
S18
Shamberger RC et al. (1981) Effects of high-dose methotrexate and vincristine
on ovarian and testicular functions in patients undergoing postoperative adjuvant
treatment of osteosarcoma. Cancer Treat Rep 65: 739–746
S19
Grunnet
E
et
al.
(1977)
Studies
of
human
semen
in
topical
corticosteroid-treated and in methotrexate-treated psoriatics. Dermatologica 154: 78–84
S20
Hensley ML and Ford JM (2003) Imatinib treatment: specific issues related to
safety, fertility, and pregnancy. Semin Hematol 40: 21–25
S21
Spinelli S et al. (1994) Ovarian recovery after total body irradiation and
allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone
Marrow Transplant 14: 373–380
S22
Schimmer AD et al. (1998) Ovarian function after autologous bone marrow
transplantation. J Clin Oncol 16: 2359–2363
S23
Jacob A et al. (1998) Recovery of spermatogenesis following bone marrow
transplantation. Bone Marrow Transplant 22: 277–279
S24
Littley MD et al. (1991) Endocrine and reproductive dysfunction following
fractionated total body irradiation in adults. Q J Med 78: 265–274
S25
Heimpel H et al. (1991) Gonadal function after bone marrow transplantation in
adult male and female patients. Bone Marrow Transplant 8 Suppl 1: 21–24
S26
Sanders JE (2004) Endocrine complications of high-dose therapy with stem
cell transplantation. Pediatr Transplant 8 Suppl 5: 39–50
S27
Grigg AP et al. (2000) Reproductive status in long-term bone marrow
transplant survivors receiving busulfan-cyclophosphamide (120 mg/kg). Bone Marrow
Transplant 26: 1089–1095
S28
Chatterjee R et al. (1994) Germ cell failure and Leydig cell insufficiency in
post-pubertal males after autologous bone marrow transplantation with BEAM for
lymphoma. Bone Marrow Transplant 13: 519–522
S29
Somali M et al. (2005) Function of the hypothalamic-pituitary-gonadal axis in
long-term survivors of hematopoietic stem cell transplantation for hematological
diseases. Gynecol Endocrinol 21: 18–26
S30
Chatterjee R et al. (2001) Patterns of Leydig cell insufficiency in adult males
following bone marrow transplantation for haematological malignancies. Bone Marrow
Transplant 28: 497–502
S31
Whitehead E et al. (1982) The effects of Hodgkin's disease and combination
chemotherapy on gonadal function in the adult male. Cancer 49: 418–422
S32
Chapman RM et al. (1979) Cyclical combination chemotherapy and gonadal
function. Retrospective study in males. Lancet. 1: 285–289
S33
Waxman JH et al. (1982) Gonadal function in Hodgkin's disease: long-term
follow-up of chemotherapy. Br Med J (Clin Res Ed). 285: 1612–1613
S34
Viviani S et al. (1985) Gonadal toxicity after combination chemotherapy for
Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol
21: 601–605
S35
Anselmo AP et al. (1990) Risk of infertility in patients with Hodgkin's disease
treated with ABVD vs MOPP vs ABVD/MOPP. Haematologica 75: 155–158
S36
Clark ST et al. (1995) Gonadal function following chemotherapy for Hodgkin's
disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol
13: 134–139
S37
Kreuser ED et al. (1987) Reproductive and endocrine gonadal capacity in
patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin
Oncol 113: 260–266
S38
Charak
BS
et
al.
(1990)
Testicular
dysfunction
after
cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced
Hodgkin's disease. A long-term follow-up study. Cancer 65: 1903–1906
S39
Viviani S et al. (1999) Long-term results of an intensive regimen: VEBEP plus
involved-field radiotherapy in advanced Hodgkin's disease. Cancer J Sci Am 5:
275–282
S40
Viviani S et al. (1991) Testicular dysfunction in Hodgkin's disease before and
after treatment. Eur J Cancer. 27: 1389–1392.
S41
Kulkarni SS et al. (1997) Gonadal function following ABVD therapy for
Hodgkin's disease. Am J Clin Oncol 20: 354–357
S42
Kreuser ED et al. (1992) Long-term gonadal dysfunction and its impact on
bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's
disease. Ann Oncol 3 Suppl 4: 105–110
S43
Bokemeyer C et al. (1994) Long-term gonadal toxicity after therapy for
Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 68: 105–110
S44
Pryzant RM et al. (1993) Long-term reduction in sperm count after
chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. J Clin
Oncol 11: 239–247
S45
Radford JA et al. (1994) Male fertility after VAPEC-B chemotherapy for
Hodgkin's disease and non-Hodgkin's lymphoma. Br J Cancer 69: 379–381
S46
Muller U and Stahel RA (1993) Gonadal function after MACOP-B or
VACOP-B with or without dose intensification and ABMT in young patients with
aggressive non-Hodgkin's lymphoma. Ann Oncol 4: 399–402
S47
Hill M et al. (1995) Evaluation of the efficacy of the VEEP regimen in adult
Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol 13:
387–395
S48
Roeser HP et al. (1978) Testicular damage due to cytotoxic drugs and recovery
after cessation of therapy. Aust N Z J Med 8: 250–254
S49
Santoro
A
et
al.
(1987)
Long-term
results
of
combined
chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus
radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5: 27–37
S50
Waxman J et al. (1983) Gonadal function in men treated for acute leukaemia.
Br Med J (Clin Res Ed) 287: 1093–1094
S51
Leung W et al. (2000) Late effects of treatment in survivors of childhood acute
myeloid leukemia. J Clin Oncol 18: 3273–3279
S52
Wallace WH et al. (1991) Male fertility in long-term survivors of childhood
acute lymphoblastic leukaemia. Int J Androl 14: 312–319
S53
Wallace WH et al. (1993) Ovarian function following the treatment of
childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 21: 333–339